US Stock MarketDetailed Quotes
FNCH Finch Therapeutics
- 12.050
- +0.600+5.24%
15min DelayClose Nov 22 16:00 ET
19.35MMarket Cap-1369P/E (TTM)
12.050High11.400Low4.46KVolume11.445Open11.450Pre Close52.51KTurnover0.64%Turnover RatioLossP/E (Static)1.61MShares14.26052wk High1.36P/B8.38MFloat Cap0.80052wk Low--Dividend TTM695.02KShs Float675.000Historical High--Div YieldTTM5.68%Amplitude0.800Historical Low11.772Avg Price1Lot Size
Finch Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | -87.57%107K | 0 | 0 | 0 | -69.77%107K | -95.35%861K | -99.01%8K | -98.78%138K |
| Operating revenue | --0 | --0 | -87.57%107K | --0 | --0 | --0 | -69.77%107K | -95.35%861K | -99.01%8K | -98.78%138K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -32.72%6.11M | -68.92%5.16M | -61.70%34.11M | -77.27%4.68M | -82.58%3.74M | -58.89%9.08M | -33.37%16.61M | 13.42%89.06M | 3.64%20.59M | 0.78%21.44M |
| Selling and administrative expenses | -31.18%6.11M | -46.30%5.16M | -25.65%26.91M | -48.22%4.68M | -61.03%3.74M | 8.73%8.88M | 2.26%9.62M | 70.41%36.19M | 78.48%9.04M | 67.00%9.58M |
| -General and administrative expense | -31.18%6.11M | -46.30%5.16M | -25.65%26.91M | -48.22%4.68M | -61.03%3.74M | 8.73%8.88M | 2.26%9.62M | 70.41%36.19M | 78.48%9.04M | 67.00%9.58M |
| Research and development costs | --0 | --0 | -86.38%7.2M | --0 | --0 | -98.54%203K | -54.95%7M | -7.71%52.86M | -21.97%11.55M | -23.67%11.86M |
| Operating profit | 32.72%-6.11M | 68.71%-5.16M | 61.45%-34M | 77.26%-4.68M | 82.47%-3.74M | 58.21%-9.08M | 32.85%-16.51M | -47.03%-88.19M | -7.98%-20.58M | -114.49%-21.31M |
| Net non-operating interest income expense | -45.95%227K | -34.12%280K | 523.02%1.57M | 28.57%333K | 771.11%392K | 746.15%420K | 3,169.23%425K | 1,045.45%252K | 3,137.50%259K | 462.50%45K |
| Non-operating interest income | ---- | ---- | 523.02%1.57M | ---- | ---- | ---- | ---- | 1,045.45%252K | ---- | ---- |
| Total other finance cost | 45.95%-227K | 34.12%-280K | ---- | ---- | -771.11%-392K | -746.15%-420K | ---425K | ---- | ---- | -462.50%-45K |
| Other net income (expense) | -38.71%1.05M | 102.03%1.01M | -71.45%-45.78M | 119.55%1.31M | 104.85%927K | 288.12%1.71M | -49.73M | -1,581.09%-26.7M | -668,300.00%-6.68M | -63,603.33%-19.11M |
| Special income (charges) | --0 | 99.93%-34K | -81.84%-49.84M | 104.28%307K | 99.65%-68K | 177.56%705K | ---50.78M | -1,577.41%-27.41M | ---7.17M | ---19.33M |
| -Less：Restructuring and merger&acquisition | --0 | -98.95%34K | 58.03%3.82M | -209.05%-265K | -96.38%46K | -11.30%801K | --3.24M | --2.42M | --243K | --1.27M |
| -Less:Impairment of capital assets | --0 | --0 | 84.29%46.04M | --0 | --0 | --0 | --46.04M | --24.98M | --6.93M | --18.06M |
| -Less:Other special charges | ---- | ---- | --614K | --0 | ---- | ---752K | --1.37M | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | 9,200.00%637K | 4,300.00%42K | ---22K | 12,666.67%754K | ---137K | -125.00%-7K | ---1K | --0 |
| Other non- operating income (expenses) | 4.28%1.05M | -1.04%1.04M | 477.35%4.05M | 105.76%1M | 360.65%995K | --1.01M | --1.05M | 1,450.00%702K | 48,700.00%486K | 820.00%216K |
| Income before tax | 30.45%-4.83M | 94.11%-3.88M | 31.78%-78.22M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -167.87%-65.81M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M |
| Income tax | 0 | 0 | -3.46M | 0 | 0 | 0 | -3.46M | 0 | 0 | 0 |
| Net income | 30.45%-4.83M | 93.78%-3.88M | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -153.78%-62.35M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M |
| Net income continuous Operations | 30.45%-4.83M | 93.78%-3.88M | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -153.78%-62.35M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 30.45%-4.83M | 93.78%-3.88M | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -153.78%-62.35M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 30.45%-4.83M | 93.78%-3.88M | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -153.78%-62.35M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M |
| Basic earnings per share | 30.48%-3.01 | 93.85%-2.41 | 35.40%-46.59 | 88.75%-1.89 | 94.05%-1.51 | 69.74%-4.33 | -151.22%-39.19 | -62.43%-72.12 | -40.00%-16.8 | -302.86%-25.38 |
| Diluted earnings per share | 30.48%-3.01 | 93.85%-2.41 | 35.40%-46.59 | 88.75%-1.89 | 94.05%-1.51 | 69.74%-4.33 | -151.22%-39.19 | -62.43%-72.12 | -40.00%-16.8 | -302.86%-25.38 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data